Qatar Airways is finalizing a deal to buy around 100 widebody jets from Boeing , with an option to buy as many more, Bloomberg News reported on Tuesday, citing people familiar with the matter.

If istaroxime is granted the new chemical entity designation from FDA, it could provide 7.5 years of U.S. exclusivity and additionally the istaroxime U.S. issued method of use patent protects until 2039 for its planned initial indication in cardiogenic shock If istaroxime is granted the new chemical entity designation from FDA, it could provide 7.5 years of U.S. exclusivity and additionally the istaroxime U.S. issued method of use patent protects until 2039 for its planned initial indication in cardiogenic shock

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

McKesson's fourth-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.

VNOM Q1 earnings gain from higher crude oil, natural gas and natural gas liquids production, though the gain is partially offset by a revenue miss due to lower average oil-equivalent price realization.

SHEL is reportedly assessing a bold takeover of BP, as weak oil prices and activist pressure spark speculation of major energy sector consolidation.

Celsius Holdings Inc. (CELH) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.27 per share a year ago.

Ducommun (DCO) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.70 per share a year ago.

Ingredion (INGR) came out with quarterly earnings of $2.97 per share, beating the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.08 per share a year ago.

KBR Inc. (KBR) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.77 per share a year ago.

Northwest Natural (NWN) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $2.09 per share. This compares to earnings of $1.69 per share a year ago.

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.20 per share a year ago.

Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to earnings of $0.34 per share a year ago.

Yum China reported strong 1Q25 results with better-than-expected same-store sales growth and restaurant margins, aided by temporary and permanent store closures. We are positive on YUMC's consistent execution amid China's weak macro backdrop, expecting continued menu innovation and unique store concepts to drive traffic. KCOFFEE's 20% y/y growth and PH's WOW concept are key drivers, expanding YUMC's market presence and offering value-oriented options for consumers.

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=147112&wire=1 or contact Joseph E. Levi, Esq.

Palantir delivered an exceptional Q1, showcasing significant growth in customer base and revenue, but its current valuation seems detached from fundamentals. Despite impressive metrics, including 39% YoY revenue growth and high-margin operations, PLTR's valuation at over 500 times net income is concerning. Risks include potential declines in interest income due to Fed rate cuts and intense competition from giants like Microsoft.

Camden National Reaches $7.0 Billion in Total Assets as it Successfully Completes the Acquisition of Northway Financial, Inc. in the First Quarter CAMDEN, Maine , May 6, 2025 /PRNewswire/ -- Camden National Corporation (NASDAQ: CAC; "Camden National" or the "Company") reported earnings for the quarter ended March 31, 2025 of $7.3 million and diluted earnings per share ("EPS") of $0.43. Reported earnings include the effects of the acquisition of Northway Financial, Inc. ("Northway") and its subsidiary, Northway Bank, that was completed on January 2, 2025, in an all-stock transaction through the issuance of 2.3 million shares of Camden National common …

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Datadog reports an adjusted profit of 46 cents a share in the first quarter, beating forecasts for 43 cents.

We are likely headed into a recession. Cyclical stocks have sold off significantly. Some of them are now deeply undervalued and could present significant upside potential in a future recovery.